Influenza A virus hemagglutinin: from classical fusion inhibitors to proteolysis targeting chimera-based strategies in antiviral drug discovery
The influenza virus glycoprotein hemagglutinin (HA) participates in critical steps of the attachment of viral particles to the host cell membrane receptor and membrane fusion. Due to its crucial involvement in the initial phases of influenza A infections, HA emerges as a promising target in the sear...
Saved in:
Main Authors: | Francisco Javier Hermoso-Pinilla, Aitor Valdivia, María-José Camarasa, Tiziana Ginex, Francisco Javier Luque |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration
2024-02-01
|
Series: | Exploration of Drug Science |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A100837/100837.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential application of proteolysis targeting chimera (PROTAC) modification technology in natural products for their targeted protein degradation
by: Guliang Yang, et al.
Published: (2022-03-01) -
Non-enzymatic protein targeting agents as a promising strategy for cancer treatment
by: Madison Ambrose, et al.
Published: (2025-01-01) -
Organophosphate esters inhibit enzymatic proteolysis through non-covalent interactions
by: Zeming Wang, et al.
Published: (2025-01-01) -
A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen
by: Mengyuan Liu, et al.
Published: (2025-01-01) -
Single Dose of Attenuated Vaccinia Viruses Expressing H5 Hemagglutinin Affords Rapid and Long-Term Protection Against Lethal Infection with Highly Pathogenic Avian Influenza A H5N1 Virus in Mice and Monkeys
by: Fumihiko Yasui, et al.
Published: (2025-01-01)